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Abstract
Background: Global mRNA amplification has become a widely used approach to obtain gene
expression profiles from limited material. An important concern is the reliable reflection of the
starting material in the results obtained. This is especially important with extremely low quantities
of input RNA where stochastic effects due to template dilution may be present. This aspect remains
under-documented in the literature, as quantitative measures of data reliability are most often
lacking. To address this issue, we examined the sensitivity levels of each transcript in 3 different cell
sample sizes. ANOVA analysis was used to estimate the overall effects of reduced input RNA in
our experimental design. In order to estimate the validity of decreasing sample sizes, we examined
the sensitivity levels of each transcript by applying a novel model-based method, TransCount.
Results: From expression data, TransCount provided estimates of absolute transcript
concentrations in each examined sample. The results from TransCount were used to calculate the
Pearson correlation coefficient between transcript concentrations for different sample sizes. The
correlations were clearly transcript copy number dependent. A critical level was observed where
stochastic fluctuations became significant. The analysis allowed us to pinpoint the gene specific
number of transcript templates that defined the limit of reliability with respect to number of cells
from that particular source. In the sample amplifying from 1000 cells, transcripts expressed with at
least 121 transcripts/cell were statistically reliable and for 250 cells, the limit was 1806 transcripts/
cell. Above these thresholds, correlation between our data sets was at acceptable values for
reliable interpretation.
Conclusion: These results imply that the reliability of any amplification experiment must be
validated empirically to justify that any gene exists in sufficient quantity in the input material. This
finding has important implications for any experiment where only extremely small samples such as
single cell analyses or laser captured microdissected cells are available.
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Standard protocols for microarray analysis are generally
based on samples with more than 1–5 µg of total RNA.
However, there is an increasing interest in transcription
profiling of small samples, as large amounts of material
can be difficult, if not impossible, to obtain in both clini-
cal and experimental settings. Fine needle aspirates (FNA)
(~1–2 µg) and fine needle core biopsies (~2 µg of total
RNA) offer feasible, atraumatic clinical sampling proce-
dures of limited material. Advances in technology
designed for selective collection of specialized cells such
as laser capture microdissection (LCM), yields homoge-
nous minute material for further analysis. Following
standard protocols in a pilot study, Assersohn et al. [1]
had to exclude 85% of the FNA of breast cancer samples
from further microarray analysis due to insufficient mate-
rial. The most common strategy to circumvent the large
material requirement using a standard procedure has been
to amplify the starting mRNA. The procedure for global
mRNA amplification can be performed either linearly,
using T7-based in vitro transcription [2-4] or exponen-
tially, using a PCR-based amplification [5] or a combina-
tion of both [6]. These methods all include an initial
reverse transcription. For the linear method, the yield is
103 to 106 fold amplification when using from one to
three rounds of amplification, while an even higher fold
up-scaling is possible using exponential amplification.
Using either method one can technically amplify RNA
from a single cell for gene expression analysis. The proto-
cols for linear and exponential amplification have been
subjected to optimizations [7-9], and a number of varia-
tions have been described, such as SMART-PCR [10] and
Terminal continuation (TC) RNA amplification [11].
However, the most important issue for any amplification
protocol to be used in combination with quantitative
analysis of gene expression, is that the relative transcript
abundance present in the initial mRNA sample is main-
tained throughout the procedure. In a previous study, we
found that the gene expression ratios were not completely
preserved between linearly amplified (from 200 ng total
RNA) and non-amplified material [12]. Microarray exper-
iments are subjected to variability from a range of sources,
and under the experimental conditions applied, we
showed that the impact of amplification was increased
noise in the form of ratio distortions for some genes [12].
In this study we applied an ANOVA approach to examine
the effects of variation as we reduced the amount of total
RNA in the first round of aRNA production. We explored
the lower range of RNA input that was technically feasible
in our hands. A main concern is the lower sensitivity lim-
its with respect to reliable data obtained from minute
samples. This highly relevant issue remains under-docu-
mented in the literature. The presently published reports
are focused on descriptive analysis of results from ampli-
fication from minute samples.
Furthermore, estimates of sensitivity limits have in these
applications generally been defined as the minimum
detectable abundance level that can be quantified in the
respective protocols. Quantitative measures of reliability
of the obtained data are most often lacking. In the two
seminal papers first presenting detailed mRNA amplifica-
tion protocols for use with microarray technology, the
general consensus was a decrease in correlation coeffi-
cients and concordance when evaluating diminishing
input RNA amounts [3,4]. Increased discrepancies
between the data sets when comparing the input total
RNA range of 200 ng, 10 ng and 2 ng against 10 ug input
were observed [4]. Goley et al. [13] showed that serial
dilution of RNA subjected to amplification resulted in
increased dissimilarities when compared to unamplified
RNA. Several studies have shown that starting with
minute samples in the initial amplification round, the
number of genes detected with sufficient signal for further
analysis decreased [14-16]. Reducing the number of cells
under investigation to approximately 1000 cells, Mohr et
al. [16] observed that only 19% of the 9850 genes dis-
played a signal at least two times more than the back-
ground signal. A total of 79% of the genes detected had
signals above background, indicating that the majority of
genes were in the low to moderate expression range. For
the examination of lower sensitivity levels, there are exam-
ples of studies that have applied spiked transcripts of
known concentration [17,18]. Using a PCR based ampli-
fication strategy for single cell analysis, a limit of 80 copies
per cell was reported to be the lower range for registration
of two fold changes in input RNA [18].
For the purpose of applying mRNA amplification and
small sized samples in future studies, we chose to define
the lower sensitivity limit of an mRNA amplification pro-
tocol as the number of mRNA copies needed not only to
be detectable but more importantly, produce reliable
data. Unlike previous studies, our goal was to quantita-
tively analyze the reliability of expression data for each
transcript present on our arrays as we reduced input RNA
material and thus to deduce a transcript dependent cut-off
limit with respect to reliability. We applied a novel model-
based method, TransCount [19], that estimates absolute
transcript concentrations from expression data for each
examined sample. We observed the role of stochastic per-
turbations on the amplification of small number of reac-
tant mRNA molecules. Stochastic noise dominating the
signal in amplified mRNA analysis has not been acknowl-
edged in previous reports. With the strategy of computing
correlation coefficients between transcript concentrations
for two different samples, the sensitivity limits of other
amplification methods can also be validated. More
importantly, the procedure provides a rational basis for
the selection of genes that possess true predictive power.Page 2 of 16
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Descriptive statistics
Total RNA was isolated from three aliquots of 10 000 MT-
1 cells and amplified as undiluted reference material.
Cells were diluted to obtain aliquots of 1000 and 250 test
cell samples. Total RNA isolated from parallel aliquots of
10 000 cells not used in this study, yielded an average of
115 ng when measured using a Nano Chip assay on the
Agilent Bioanalyzer. On the same Nano Chip, total RNA
from 1000 cells was not detectable. We therefore used 115
ng from 10 000 cells as a reference for relevant RNA calcu-
lations in this paper. It is important to emphasize that
these downstream RNA calculations, such as amplifica-
tion factors, only provide estimates and do not reflect
sampling errors present during cell aliquot preparations
that have undoubtedly influenced the actual yields meas-
ured. Hence, we infer that the total RNA yield from 1000
and 250 HeLa cells is approximately 11,5 ng and 2,88 ng
respectively (Table 1). In addition to RNA from the cells,
all samples were spiked with synthetic RNA transcripts
obtained from the Lucidea Universal Scorecard kit to
monitor the amplification procedure and used for infer-
ence purposes to bootstrap the transcript concentration
calculations. These transcripts also served as carriers
throughout the multistep amplification procedure. The
fraction of mRNA in the total RNA is in the range of 1–3%
and by applying the theoretical average of 2% mRNA we
have summarized the estimated mRNA input values for
each cell size sample (Table 1). We calculated that the
average fold amplification factor after two rounds in these
three cell size samples (10 000, 1000 and 250) was 1.0 ×
104, 0.69 × 104 and 0.89 × 104, respectively (Table 1). The
purity of the aRNA samples was measured by absorbance
readings. With the exception of one 250 cell batch (ratio
= 1.8), the ratios obtained by absorbance measurements
were between 2.0–2.6 for all samples. The size distribu-
tion of the aRNA products were visualized using an Agi-
lent Bioanalyzer assay. The distribution peaked at
approximately 500 bp for all samples (data not shown).
Products from 1000 and 250 cells were not larger than
1000 bp, while for the reference sample of 10 000 cells,
they were detectable up to 2000 bp. Distinctive peaks rep-
resenting the most concentrated Scorecard transcripts
could be observed on the graphs (graphs not shown).
Using a dye swap strategy, we analyzed data from six
hybridizations with 10 000 cells versus 1000 cells and six
hybridizations with 10 000 cells versus 250 cells, making
a total of twelve arrays (Figure 1). On average, 25% of the
spots (n = 11791) were filtered from arrays hybridized
with material amplified from 1000 cells in the test chan-
nel, compared to 37% of the genes filtered when ampli-
fied RNA from 250 cells was in the test channel. The data
for each filtering per array is presented in Table 2. Exam-
ining the filtering of weak spots for each set of cell size
samples separately, we found that the average number of
signals scored was 20% and 33% less for 1000 and 250
cell samples, respectively, when the reference sample (10
000 cells) was set to 100% (data not shown). These figures
are partially confounded by reduced target material
labelled in the test samples.
Array quality index
The potential problem of using inadequate or poor qual-
ity input RNA in the test channel is relatively uniform sig-
nal intensities because of low fluorescence signals. In such
cases the reference channel, which is normally designed to
provide a large dynamic range of consistent signal intensi-
ties, will be the driving force of the ratio calculations and
hence there will be a correlation between gene expression
ratios and the signal intensities of the reference channel.
To examine this potential problem we used two parame-
ters of array quality index as described by Assersohn et al.,
[1]. We first examined the SD of the log 10-based signal
intensities in the test channel (material from 1000 or 250
cell samples) as a measure of the dynamic range. The span
was between 0.59 – 0.3 for all the arrays (Table 3). For
1000 and 250 cell samples the mean value was 0.48 and
0.38 respectively. A defined minimum threshold value for
the SD of the signal intensities was not firmly established
in the study by Asserhohn et al., [1]. However they applied
0.25 as a minimum requirement. In a preliminary test
hybridization, we used 0.2 µg aRNA diluted from one of
the reference samples as target material in one of the chan-
nels and for comparison, we calculated the SD of the sig-
nal intensities for this channel to be 0.5. In the twelve
arrays analyzed in this study, the SD's of the signal inten-
sities obtained from the test channel were comparable or
higher (0.45 – 0.59) in 50% of the hybridizations. No
Table 1: Estimates of input RNA quantities and resulting yield for 10 000 cells (reference) and 1000 and 250 cells (test), respectively. 
Calculation of the average fold yield of aRNA after two rounds of amplification are based on the assumption that 2% of total RNA 
represents mRNA.
Cell sample size ~Total RNA ~mRNA
(2% of total RNA)
Synthetic mRNA Sum mRNA Average aRNA yield Average amplification
factor
10 000 ~115 ng ~2.3 ng 3.0 ng 5.3 ng 54 µg 1.02 × 104
1000 ~11.5 ng ~0.23 ng 0.3 ng 0.53 ng 3.66 µg 0.69 × 104
250 ~2.88 ng ~0.058 ng 0.075 ng 0.133 ng 1.18 µg 0.89 × 104Page 3 of 16
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Table 2: Filtering per array.
Arrays hybridized with sample size 1000 cells Arrays hybridized with sample size 250 cells
Array number 2 12 1 3 4 11 mean (SD) 6 9 7 5 8 10 mean (SD)
Genes flagged by Genepix 1189 1188 2344 1105 1272 456 1259 (556.2) 1731 1726 1155 1009 4466 3798 2314 (1327)
10.08% 10.08% 19.98% 9.37% 10.79% 3.87% 10.7% 14.68% 14.64% 9.80% 8.56% 37.88% 32.21% 19.6%
Genes flagged manually 10 17 42 27 21 51 28 (14.3) 21 11 104 359 29 69 98.8 (120.6)
0.08% 0.14% 0.36% 0.23% 0.18% 0.43% 0.2% 0.18% 0.09% 0.88% 3.04% 0.25% 0.59% 0.8%
Additionally filtered by spot-background>2× standard 
deviation of background
113 261 3459 2455 2229 1390 1651 (1198) 1602 562 2020 1292 3886 2184 1924 (1023)
0.01% 2.21% 29.34% 20.82% 18.90% 11.79% 13.9% 13.59% 4.77% 17.13% 10.96% 32.96% 18.52% 16.3%
Sum 1312 1466 5934 3587 3522 1897 2953 (1614) 3354 2299 3279 2660 8381 6051 4337 (2173)
10.17% 12.43% 49.68% 30.42% 29.87% 16.09% 24.8% 28.45% 19.50% 27.81% 22.56% 71.09% 51.32% 36.8%
Table 3: Array quality index. The SD of the log10-intensities in channel 1 give an indication of the dynamic range obtained from the test samples (1000 or 250 cell samples). The 
correlation coefficients between gene expression log10-ratios of the experiment and log10-intensities of channel 2 (reference sample) were calculated to confirm that the gene 
expression ratios are not determined by the signal intensities of the reference channel.
Arrays hybridized with sample size 1000 cells Arrays hybridized with sample size 250 cells
Array number 2 12 1 3 4 11 mean 6 9 7 5 8 10 mean
Standard deviation of test channel signal intensity 0.6 0.49 0.3 0.39 0.52 0.59 0.48 0.45 0.53 0.3 0.34 0.3 0.38 0.38
Correlation ratio vs. reference channel signal intensities 0.13 0.23 0.35 0.29 0.26 0.2 0.24 0.27 0.28 0.26 0.25 0.48 0.43 0.33
BMC Genomics 2005, 6:147 http://www.biomedcentral.com/1471-2164/6/147array had a SD lower 0.3. Hence, we found these magni-
tudes to be sufficient for the arrays to be used in further
analysis and verified by calculating the correlation
between log10-ratios and the log10-intensities of signals in
the reference channel to ensure that the gene expression
ratios were not dominated by the reference target which
was prepared from a larger amount of input RNA. The cor-
relations calculated for the twelve arrays were in the order
of 0.13 – 0.48, with a mean value of 0.24 and 0.33 for the
1000 and 250 cell samples respectively (Table 3). In com-
parison, the correlation obtained from two self -self exper-
iments with either even and uneven target preparation in
a pilot study was 0.01 and 0.117 respectively. Hence, due
to lack of evident correlation between gene expression
ratios and reference channel signal intensities, we can
exclude the potential domination of the reference channel
due to uneven targeting on the arrays used in this study.
Multiple hypothesis testing
From these self-self experiments, the expected log2-ratio
values from the processed data were 0 for each gene in
every microarray experiment, assuming no influence of
material quantity in the initial steps of the amplification.
However, the reduced number of genes detected above
background levels indicated that low signals correspond-
ing to moderate or low-copy transcripts were potentially
more affected by background noise and thus less likely to
correlate when performing expression level comparisons
to a reference. In our previous report, we found that tran-
script dependent bias was not apparent in the optimal
starting amount (200 ng total RNA) of the amplification
protocol [12]. However, by drastically reducing input
RNA in the amplification reaction, we observed in this
study that the levels of detection were altered and variabil-
ity introduced. To assess the observed variability in gene
expression ratios, we used multiple hypothesis testing to
identify genes with log2-ratios statistically significantly
different from 0. The statistical analyses were based on fil-
tered, transformed, normalized and dye-swap averaged
data using a moderated t-test. P-values were calculated
based on empirical Bayes t-test [20]. For the 10 000 versus
1000 cells experiments, we estimated the proportion of
genes not differentially expressed to be 66.3%. Using a
false discovery rate (FDR) cut-off of 0.05, we found 179
features (1.8%) that were significantly differentially
expressed. For the 10 000 versus 250 cells experiments we
estimated the proportion of genes not differentially
expressed to be 57.1% and a FDR cut-off of 0.05 resulted
in a list of 639 features (6.1%) that were statistically sig-
nificant differential gene expression. Interestingly,
between the two sets of significantly differentially
expressed genes, there were 110 features in common. We
found no connection between these 110 features with
respect to signal intensity range or length of probe on
array. We extracted the estimated transcript concentra-
tions for these features and found the values for 82 fea-
tures, representing 70 genes, as some were printed in
duplicates on the array. As expected there was a large con-
centration span. For the 10 most concentrated genes, with
the exception of one gene, the high transcript abundance
was not maintained in the test samples compared to the
reference samples as deduced from the respective raw
data. For the remaining 60 genes, the general trend was
equal or higher signal intensities in the test samples with
respect to the reference channel. After normalization,
these genes were overexpressed in the test samples, and
hence, significantly differentially expressed.
ANOVA analysis
We assumed that the variance observed between test sam-
ples and the reference was due to limited material in the
test samples. To investigate this assumption we identified
Table 4: Parameter estimates in the ANOVA model. This is a mixed-effects model, as the first three effects are fixed and the others 
are random. The noise in these experiments was largely due to gene and to the interaction between replicates and gene. Reduction in 
samples size yielded increased noise since 
Fixed Effect Explanation Estimated value
µ Fixed overall level -0.13
C Sample size; 1000 or 250 cells 0.055
D Dye ratio; cy3/cy5 or cy5/cy3 0.10
Random effects E~N(0, σ2E) Explanation Estimated standard deviation ( )
A Array; 1,...,12 0.14
G Gene; 1,...10643 0.47
CG Interaction: cell size sample and gene 0.044
BG Interaction: replicate (10 000 cells) and gene 0.17
B1G Interaction: replicate (1000 cells) and gene 0.41
B2G Interaction: replicate (250 cells) and gene 0.45
DG Interaction: dye ratio and gene 0.18
ε Model and measurement error 0.33
ˆ ˆ ˆσ σ σBG B G B G< <1 2
σˆEPage 5 of 16
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structed an ANOVA model to estimate their importance,
and thus isolate the effect of reduced starting material. The
estimated contributions from the sources of variation
modelled are presented in Table 4. We noted that µ, C, D
and A were small as expected since the ratios are normal-
ized. The dye-gene (DG) interaction was of moderate size,
possibly as a result of difference in amount labelled in the
two channels. The cell sample size-gene (CG) interaction
was small, indicating that the noise due to differences
between sample size 1000 and 250 cells was quite small.
In accordance with the results from multiple hypothesis
testing, the gene effect (G) was relatively high. For the
interaction between replicates and gene (BG, B1G, B2G),
we obtained the gradient of noise level in the expected
order, from the lowest in 10 000 cells to the highest in 250
cells. There was a relatively small difference between the
1000 and 250 replicates.
Absolute transcript concentration estimates and cut-off 
limits for unreliable data
Larger replicate-gene (B1G and B2G) interactions obtained
from the ANOVA analysis imply a greater degree of unre-
liable data present in the data set obtained from reduced
samples. To strengthen possible biological findings in
small samples, it is of great value to remove uncertain
measurements. Empirically, observations suggested that
these measurements were characterized by low signals
related to low transcript abundance. We applied the
TransCount model as an approach to eliminate unreliable
data based on quantitative measures of template input in
the initial amplification and for the threshold determina-
tion. With TransCount we found estimates of transcript
concentrations for each gene per sample. For the reference
(10 000 cells), a conversion factor was calculated for
obtaining absolute concentrations. The conversion factor
was generated by first estimating the concentrations esti-
mates of the synthetic Scorecard templates, and secondly,
deducing the factor by using linear regression. The abso-
lute concentrations of each of 8116 genes present in the
reference sample (10 000 cells) were estimated. For values
above 0 (n = 8085), the range was between 0.3 and 40 000
transcripts per gene in an MT-1 cell. These quantities rep-
resent the contents of one cell prior to amplification. Mul-
tiplying by 10 000 cells, the amplification factor and the
fraction of aRNA used for labeling, the range was between
5.8 × 105 and 7.8 × 1010 transcripts per gene in the labelled
cDNA pool that was applied to the array and represented
the reference channel (Table 5). For this calculation, we
assumed efficient conversion from aRNA to cDNA. Using
TransCount, we obtained, in addition to the transcript
concentrations for each gene and sample, the posterior
joint probability distribution of all concentrations. This
distribution could be used for computing various distri-
Experimental designFigu e 1
Experimental design. Three replicates of each cell size 
sample were amplified. Each reference replicate B (10 000 
cells) was hybridized to test samples B1 (1000 cells) and B2 
(250 cells), respectively, in a dye-swap strategy. The arrows 
represent arrays, alternating in direction to indicate dye-
swap. In total, six arrays were used for each test sample size 
versus reference.
Table 5: Conversion of gene transcripts per cell to gene transcripts applied to the array. The number of molecules per gene hybridized 
to the array varied between 5.8 × 105 – 7.8 × 1010 with respect to the reference sample. The reliability threshold in terms of minimum 
number of molecules per gene applied to arrays for 250 cells, 6.8 × 108, was six times higher than the threshold for 1000 cells.
Cell sample size Description Copies per cell Amplification factor Fraction aRNA 
labeled
Equivalent number of 
molecules applied to 
array
10 000 reference transcript 
concentration range
0.3 – 40 000 1.02 × 104 0.019 5.8 × 105 – 8.1 × 1010
1000 reliability threshold 121 0.69 × 104 0.137 1.1 × 108
250 reliability threshold 1806 0.89 × 104 0.169 6.8 × 108Page 6 of 16
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a and b. Correlation of transcript concentration estimatesFigure 2
a and b. Correlation of transcript concentration estimates. Using the TransCount method, we obtained for each gene 
the distribution of the correlation coefficients between the reference sample transcript concentrations and the 1000 (250) cell 
sample transcript concentrations. Summary values for a certain gene in the (mean) 1000 cell samples versus the (mean) refer-
ence samples, are plotted against the estimated concentration for the (mean) reference sample in Fig. 2a. The black solid line is 
the median correlation coefficient values. The blue and green dashed lines are the 2.5% and 97.5% quantiles, respectively. The 
vertical dashed black line is the reliability threshold 121, i.e. the value for which the probability of positive correlation is at least 
0.99. Similarly, information about the distribution for the (mean) 250 cell sample and (mean) reference is summarized in Fig 2b. 
In this case, the reliability threshold is 1806. The number of genes per concentration is shown below each respective plot. For 
a certain concentration c, the number of genes is counted from the interval 
A
B
c
c
2
2,


BMC Genomics 2005, 6:147 http://www.biomedcentral.com/1471-2164/6/147butions and probabilities. We used it for calculating the
distribution of the Pearson correlation coefficient
between the reference sample concentrations and the
1000 cell sample concentrations for each gene (Fig. 2a).
Similarly, the same procedure was performed for the ref-
erence and 250 cell samples (Fig. 2b). The graphs clearly
showed that the correlation coefficients were copy
number dependent. High copy numbers yielded high cor-
relation coefficients. As expected, fewer transcripts per
gene were necessary to obtain high correlations among
genes amplified from 1000 cells compared to genes
amplified from 250 cells. In Fig. 2a we observed a region
where certain molecules were influenced by stochastic
effects resulting in correlation coefficients alternating
between poor and good. To define a cut-off value that
ensured the exclusion of unreliable data in downstream
analysis, we calculated the probability of positive correla-
tion for each gene based on the distribution of the corre-
lation coefficients. For the 1000 (250) cell sample, the
probability of positive correlation was at least 0.99 when
concentrations were 120.881 (1806.214) or more. Hence,
in experiments using 1000 cells, the least number of tem-
plates required for further analysis was 121 copies per cell.
For 250 cells the threshold was 1806 copies per cell. To
convert the limit from minimum transcripts per gene in a
cell to minimum number of transcripts per gene in the
cDNA pool applied to the array, we multiplied by cell
sample size, amplification factor and fraction of aRNA in
the labeling reaction (Table 5). This calculated threshold
was six times higher when initially starting from 250 cells
compared to 1000 cells. With respect to the serially
diluted synthetic templates, the two most diluted calibra-
tion spikes (cYIR09 and cYIR10) in the samples with 1000
cells were below the threshold, while for 250 cell samples,
the five most diluted calibration spikes (cYIR06-cYIR10)
were below threshold. The number of genes left for anal-
ysis when applying the cut-off values 121- and 1806 cop-
ies per cell were 3149 and 390, respectively. This
represented an eight times difference of data loss when the
sample was reduced from 1000 to 250 cells. Hence, for
250 cells as input value in the amplification procedure,
only a relatively small fraction of the genes queried on the
array were suitable for further functional analysis.
We examined the signal intensity distribution of the genes
that were filtered according to the cut-off value, but not by
the weak spot filter criteria used when pre-processing the
data. We chose to investigate the genes with at least two
observations out of the three dye-swap duplicates. As
expected, the majority were in the low signal range, with a
slightly wider distribution range for data obtained from
250 cells (Fig. 3). A filtering criterion of <1500 in mean
signal intensity would remove 95% of the genes catego-
rized as unreliable by TransCount when amplifying from
1000 cells. This intensity criterion was chosen by visual
inspection of Fig. 3. However, due to the greater spread of
intensities in the 250 cell samples, a similar criterion was
more difficult to determine. A removal of 95% of the
genes required a signal >3270.
Discussion
To examine the conservation of ratio profiles between
increasingly smaller cell size samples, we performed a
series of analyses on microarray data generated from an
experimental design using one source of material, but
with varying amounts RNA into the amplification proce-
dure prior to hybridization. Many studies have applied
serially diluted RNA from the same total RNA sample to
evaluate amplification procedures [3-5,13]. However, this
does not approximate experimental conditions for sepa-
rately processing minute samples from start to finish, as is
the case in patient sample handling. Hence, the experi-
mental procedure started with isolation of total RNA from
9 independent and cell counted samples drawn from the
same cell culture. As the samples varied in size, two RNA
isolation kits were applied that each were specially
designed to cover a certain quantification range of cells.
Both kits originated from the same manufacturer. They
were based on the same chemical components and only
differing in the RNA binding capacity of the silica fiber
matrix and subsequent elution volume. Our aim was to
maximize total RNA yield as suboptimal RNA isolation
Signal intensity distribution of genes below the statistically defined hresholdFigure 3
Signal intensity distribution of genes below the statis-
tically defined threshold. Accumulation of genes in the 
low to moderate detection range when examining the mean 
signal intensity distribution of genes below the reliable 
threshold, but not filtered by the weak spot criteria. These 
genes were observed in at least two of the three dye-swap 
duplicates.Page 8 of 16
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BMC Genomics 2005, 6:147 http://www.biomedcentral.com/1471-2164/6/147from the small test samples could result in biased data. In
order to optimize the generation of amplified products
and the degree of correlation between parallel samples,
we thus chose to include the entire sample in the amplifi-
cation procedure setup. We made conservative estimates
of amplification factors, knowing that they are prone to
sampling errors in the actual number of initial cells in
each sample, in addition to variable efficiency in isolation
of total RNA. For the lower limit of input material, the
sample size was set to 250 cells, as this is, in our experi-
ence, the lower range of the amplification protocol with
respect to generating sufficient aRNA for labeling probes
in a dye-swap strategy. The aRNA yields from the small
test samples were a determining factor for the amount
used in the target labeling reactions. We applied a rela-
tively equal percentage of the aRNA yield from the two
test samples sizes for the respective labeling reactions. The
labeling amount for the reference target was set to a con-
stant value across all arrays and thus uneven target
amounts were used being aware of the confounding con-
tribution to the data filtering process. It is clear that in
realistic clinical settings, patient sample size variability
may be extensive both between patients and within the
same patient and obtaining sufficient aRNA to perform
microarray analysis from particular samples may be chal-
lenging. The essential requirement for inclusion of scarce
aRNA material in data analysis is sufficient array quality.
We used array quality index parameters to ensure ade-
quate quality of the target used in the test sample channel
and lack of reference channel domination of the gene
expression ratios (Table 3). An alternative approach to
further increase the yield of scarce material in an attempt
to equate reference target material amount in the desired
number of hybridizations, would be to introduce a third
round of amplification. Scherer et al. [21] reported that an
additional third round only had a modest effect on repro-
ducibility. However, a third round would increase the
work load, as it is optimal to compare aRNA based on
equal number of amplification rounds, and also risk pla-
teau effects with high copy gene saturation especially if
using a reference sample in the experimental design. In
fact, two rounds of amplification sufficiently upscaled
many genes to saturation levels in the reference samples
used in this study. Extending the in vitro transcription step
is not a recommended alternative for increasing aRNA
amounts due to increase in non-template based products.
In vitro transcription past four hours has been shown to
have negative effects in that the aRNA becomes degraded
and thus reduces the quality of post-amplification proce-
dures such as microarray analysis [22].
The amplification protocol we used applies to cDNA
arrays and modifications, as alternative approaches are
required for oligo arrays due to the antisense orientation
of the aRNA products.
Descriptive analyses of the twelve arrays showed a reduc-
tion of the number of genes with sufficient expression lev-
els for further analysis in the test channel representing the
aRNA generated from 1000 or 250 cells, compared to the
reference channel. However, the average number of fea-
tures scored on arrays with material from 250 cells (6300
genes) was comparable to the amount of data obtained
using 30 µg of unamplified total RNA (6400 genes) from
the same cell source on comparable array prints. Loss of
data and lowered number of genes detected in earlier
reports indicate that there is a bias for inaccurate represen-
tation of low copy number genes in the amplified pool of
aRNA from minute samples. Another important issue is
that low signals corresponding to moderate or low-copy
transcripts may be more affected by background noise and
thus less likely to correlate when performing compari-
sons. Although candidate genes may be extracted, the low
signal-to-background ratio indicates that investigators
need to be aware of the potential for inconsistent data
interpretation.
To study the proportion of inconsistent data when using
amplified material, correlation coefficient calculations
have been the main choice of statistically based analyses.
This is especially true for estimations of inconsistency in
data generated from amplified material compared to non-
amplified or from different amplification protocols
[13,23-26], However, more sophisticated statistical ana-
lytical methods have also appeared [27-30]. To analyze
the fidelity that the amplification procedure has on differ-
ential gene expression between two different samples, a
comparison of t-scores or posterior distribution of fold
change for individual genes have been applied [28-30].
The reported results from these analyses were restricted to
a small subset of genes, more specifically the outliers, e.g.
the top ranked 10 genes or genes with a fold change of >2.
Without generating specific gene subsets, we used a t-test
in our previous study to indicate the preservation of ratio
when amplifying the input material and illustrated by
plotting the ratio difference vs. the p-value for each gene.
Likewise, a similar approach was used by Schlingemann et
al., [31] to show how ratio preservation was maintained
when serially diluting the RNA amount used in their
sense-oriented amplification protocol. For the purpose of
our investigation in this study, we globally estimated the
portion of genes differentially expressed in the reference
and test samples based on p-values calculated from a
moderated t-test. Using the same sample source, the
expected log2-ratio value was 0. We found that the
number of differently expressed genes increased when
comparing the smallest test sample size (250 cells) with
the reference. The increase in differentially expressed
genes indicated increased variability when reducing sam-
ple size.Page 9 of 16
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how much variability was introduced due to technical
aspects when amplifying from very limited material. Ide-
ally, variable sample size should not affect ratio measure-
ment uncertainties. However, we showed there was a non-
negligible increase in variation when sample size
decreased. In this study, the variation was captured by the
interaction between replicate sample sizes of 1000 cells
(250 cells) and gene, BG. This estimate was of considera-
ble proportion with respect to the various sources of noise
in the ANOVA model. We found it necessary to address,
characterize and filter data affected by this variation.
The main factors possibly influencing loss and variance of
gene expression data when reducing input RNA are
sequence-dependent bias and transcript abundance bias.
In our previous work we found no statistical evidence to
support sequence dependent bias [12]. In exponential
amplification methods, the situation may be different as
DNA polymerase is more prone to sequence bias than
RNA polymerase. Transcript abundance bias was not evi-
dent in the optimal starting amount (200 ng total RNA) of
the amplification protocol and we found the degree of
transcript representation in the resulting aRNA pool with
respect to the initial total RNA transcript population to be
satisfactory for the use in gene expression analysis. We
also observed that amplification prior to microarray
hybridization increased the data output when comparing
to standard total RNA labeling and hybridization. This
was due to improved signal intensities of genes with low
transcript numbers. Hence, we were able to extract infor-
mation from a substantially larger number of genes using
amplified material compared to non-amplified. However,
by drastically reducing RNA in the reaction we are initiat-
ing amplification from samples with fewer copies of rare
transcripts and this may increase the chance of data loss
and variation due to stochastic distribution of low copy
number templates. We may classify mRNA transcript
abundance into 3 groups; high, moderate and low abun-
dance. There are about 12 000 different transcripts per cell
and over 90% of these are represented by the low-copy
abundance class, having 1–15 copies of the transcript per
cell [32]. According to SAGE data, more than 83% of tran-
script were present in one copy per cell [33]. In an
approach to examine the effects of abundance in a com-
parison between amplified and non-amplified data and
replicates within the two groups, Sheidl et al. [34] divided
the genes into 10 groups based on their intensity and
Pearson correlation coefficients were calculated for each
group respectively. The results demonstrated a clear effect
of abundance bias on the correlation. For low copy
number transcripts, the coefficient approached 0.2 as
intensity reached background levels. The high variability
in the low abundance region of both amplified and non-
amplified experiments show that this is in an unreliable
region of transcript concentration irrespective of the inclu-
sion of an amplification step [34]. A point of relevance for
comparative microarray studies can be drawn from a pre-
vious assessment of stochastic effect in quantitative PCR
[35,36]. When the queried template is present in low copy
numbers in both the test and reference sample, the varia-
tion in ratio between the two templates is dependent on
the stochastic distribution of both transcripts, resulting in
a multiplication of stochastic effects. These observations
can further be related to the term Monte Carlo effect
coined by Karrer et al. [37]. The Monte Carlo effect is
described by small, random and template concentration
dependent differences in amplification efficiency. Each
template has a certain probability of being amplified or
lost, resulting in inconsistent detection. The lower the
abundance of any template, the smaller the probability is
that its true abundance will be maintained in the ampli-
fied product. It is therefore evident that the role of sto-
chastic effects on the amplification of small number of
mRNA molecules needs to be recognized. These effects
have not previously been identified in relation to mRNA
amplification procedures and subsequent analysis. Gene
expression measurements affected by stochastic fluctua-
tions may result in highly misleading quantitative infor-
mation. It is of great advantage to the investigator to be
able to define the limit of accuracy in terms of the number
of template copies needed to avoid such obscured gene
expression measurements. Data acquired above this limit
should theoretically be sufficiently reproducible for fur-
ther biological interpretation. In a study addressing
microarray sensitivity using non-amplified material, the
minimum transcript concentration that provided reliable
measurements was defined to be the interception between
the distribution of signal intensities, with the distribution
of signal intensities from differentially expressed genes
[38]. As mentioned above, to analyze fidelity of amplifica-
tion on differential gene expression between two different
samples, comparisons of t-scores or posterior distribu-
tions of fold change for individual genes have more
recently been applied [28-30]. However, reports from the
analyses were in these cases restricted to a small subset of
genes. Maintenance of fidelity across levels of gene expres-
sion was not investigated in these studies. Until now, few
studies have presented quantitative strategies to establish
the estimated number of transcripts necessary prior to
amplification to consistently maintain the relative abun-
dance present in the un-amplified sample. The use of
spiked control transcripts of known concentration is one
method to approach this question. Using a PCR based
amplification strategy for the analysis of single cells, a
limit of 80 copies per cell was reported [18]. For two
rounds of PCR-based amplification of mRNA and subse-
quent single cell transcript profiling, the analysis of spike
controls in a single channel experiment led to a cut off
limit corresponding to 1–2 template copies per cell [39].Page 10 of 16
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thirty in the second. However, the use of two rounds of
PCR is to our knowledge limited. Another approach is to
verify and compare relative expression levels obtained
with microarray data with other quantitative technologies
to possibly set a cut-off limit. Quantitative RT-PCR is a
commonly applied technique. However, verification is
performed on a gene-by-gene basis and is not suited for a
high throughput verification of low expressing genes. Nei-
ther is fluorescent correlationspectrometry (FCS), a direct
and sensitive technology for quantification of single mol-
ecule (gene) in solution [40]. A medium throughput tech-
nique is the standardization of competitiveRT-PCR
(StaRT-PCR) [41]. This multiplex PCR technique allowed
the simultaneous expression and quantification measure-
ments of 25 genes. However, the method requires careful
design of competitive templates for each gene. Other
emerging PCR based solutions, such as SmartProbe [42],
where pre-designed primers and probes may be used to
provide quantitative information on gene expression in a
more high-throughput format. To avoid the obstacles
inherent in most of the technologies mentioned above,
and given the limited sample material, we propose the use
of high throughput absolute quantification of the respec-
tive genes and a subsequent comparison with correlation
coefficients obtained in our experimental design for estab-
lishment of a limit of accuracy for the sample cell size in
question. The first step requires acquisition of absolute
abundance data for the genes to be queried in the material
source. Other high throughput methods for quantifica-
tion of gene expression levels other than cDNA and oligo-
nucleotide arrays are represented by techniques such as
serial expression of gene expression (SAGE) [43] and mas-
sive parallel signature sequencing (MPSS) [44]. The
advantage of SAGE is that it provides absolute quantifica-
tion of transcripts compared to relative quantification
using microarrays. The disadvantage with SAGE is the
large number of clones that must be sequenced and the
method is not as widespread as microarray technology.
MPSS also allows a direct quantification like SAGE. In the
MPSS procedure, the sequencing step is modified, such
that parallel sequencing is performed directly on the solid
bead. However, the technology requires special equip-
ment and is only available through Lynx Genetics. In this
study, we have presented the successful use of TransCount
as a high throughput alternative approach for absolute
transcript concentration per gene queried on the array.
TransCount can handle experiments based on amplified
as well as non-amplified material. The results of this study
are based on cDNA array data but the model is also appli-
cable to data obtained with oligoarrays.
To characterize the genes affected by variation, we ranked
the genes in the data set according to estimated concentra-
tion of the transcripts in the reference sample (10 000
cells) and plotted the correlation coefficient on the y-axis.
The plots clearly showed that the degree of variability was
dependent on the template concentrations. This is compa-
rable with the intensity-based analyses by Sheidl et al.
[34]. To reduce variability and to correctly assess low
abundance expression ratios, they suggest replicates of the
experiment. Replicated hybridizations are not always an
option when scarce material is applied, and although
some measurements are strengthened by more observa-
tions such as those in the vicinity of background levels,
uncertainties will still revolve around others, especially
those affected by stochastic fluctuations. We proposed a
filtering strategy based on the results of TransCount. In a
sample consisting of 1000 cells, we found that at least 121
copies of a gene had to be present per cell for reliable pres-
ervation of expression level and subsequent detection.
Likewise, the threshold was 1806 per cell when only 250
cells were used. In total, these thresholds amount to 121
000 and 451 500 templates per sample size investigated.
This is a difference of 3.7 fold, which is comparable to the
dilution factor of 4. The majority of unreliable genes was
rejected if a minimum signal intensity filter of 1500 was
required in the hybridizations where 1000 cells were used
(see Fig. 3). In other words, unreliable genes are present in
the moderate signal intensity range that generally is not
considered to be a high variance range, as these signals are
well distinguished from background levels. A similar min-
imum signal requirement was not easily determined for
250 cells as unreliable genes were not only low/moder-
ately expressed, but also extended towards high expres-
sion. The reliability limit set by TransCount for the
respective sample sizes was therefore not potentially influ-
enced by unbalanced, aRNA target preparation, as large
portions of the unreliable genes were sufficiently above
background levels indicating that the threshold is in fact
determined during the initial phase of the amplification
procedure when mRNA templates are copied into cDNA.
This fact applies to all other amplification protocols, even
those with higher amplification yields than the one
applied in this study. Further, this emphasizes the need
for an alternative approach to remove biologically irrele-
vant data such as the one presented in this article where
stochastic effects were acknowledged and minimum limit
for reliable detection was devoid of such effects. Identifi-
cation of which and how many genes were available for
analysis if the sample size was further reduced was diffi-
cult to estimate with certainty given the limited number of
samples sizes in our experimental design. However,
assuming a linear trend, we can predict that for a sample
size of 100 cells, at least 1 210 000 templates per gene to
be monitored have to be present in the pre-amplification
mixture for reliable measurements. This figure translates
to 12 100 copies per cell, and for our particular RNA
source, we are left with 35 genes for analysis. In this range,
we should consider what is the reasonable minimumPage 11 of 16
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tive qualitative results even if only studying high expres-
sion genes. If our genes of interest are below the
threshold, then microarray analysis will in fact not bear
relevant information. The cut-off value, the number and
identification of genes left for downstream analyses will
vary depending on RNA source. It is evident that single
cell analysis is beyond the sensitivity of this assay.
Conclusion
For application of microarray technology combined with
amplification of mRNA from nano- to picograms of
mRNA, there is a pitfall of conferring biological relevance
to unreliable data due to transcript abundant bias altera-
tion of true gene expression. We demonstrated that with
our strategy, and the use of TransCount, we can define
limits with respect to number of transcripts necessary for
meaningful interpretation of expression data from condi-
tions using reduced input RNA, thus avoiding obscured
expression variability. As the input cell number decreased,
the necessary number of transcripts per cell increased. The
potential impact of this should be reflected in the design
of future studies. Assembling transcription concentration
data from the source material of interest using Trans-
Count should allow a prediction of which genes will pro-
vide meaningful results when minute samples of the same
source are applied.
Using the framework presented in this study also allows
evaluation of alternative amplification protocols, such as
various PCR-based strategies
Furthermore, based on our findings regarding the sensitiv-
ity limit of our amplification protocol in use, only moder-
ate to high expressing genes can be regarded in
experiments with <1000 cells. All data from low express-
ing genes should be disregarded due to inaccuracy. For
minute samples, any template diluted past a certain
threshold copy number determined by assay sensitivity,
will experience large variation in amplification whose ori-
gin is the stochastic nature of the biochemical reaction. In
the event that the gene of interest is subjected to abun-
dance dependent bias variation, only qualitative informa-
tion can be obtained. In agreement with Stenman and
Orpana [35], we conclude that quantitative expression
profiling of single cells is only potentially possible for
genes expressed at high levels that show reproducible
expression in replicate experiments. Single cell analyses
through mRNA amplification are burdened by stochastic-
ity not only in the procedure itself, but also at the level of
transcription as intrinsic noise [45], thereby severely lim-
iting the precision of gene expression measurements. It is
evident that sophisticated technologies for the selective
collection of specialized cells are a step ahead of com-
monly available, high throughput quantitative expression
profiling technologies. Caution is warranted when extrap-
olating biological relevance from the increasing number
of expression profiling results published based on
extremely low cell numbers.
Methods
cDNA arrays
The 13 k human cDNA arrays applied in this study were
printed in house with cDNA clones from the Research
Genetics 40 k cDNA clone library (Invitrogen, Carlsbad,
CA.). The cDNAs were prepared from the clone library by
PCR using M13 universal primers. The purified PCR prod-
ucts were resuspended in 3 × SSC and spotted on amino
silane coated slides (CMT GAPS, Corning Life Sciences,
Corning, NY) using a Micro Grid II robotic printer (Bio
Robotics, Cambridge, UK). After printing the slides were
cross-linked by UV to immobilize the double stranded
probes. For details on the arrays, we refer to the website
for the microarray core facility at The Norwegian Radium
Hospital [46].
RNA purification
The human carcinoma cell line, HeLa, was used through-
out the study. The cells were maintained in RPMI media
(Bio Whittaker Europe) supplemented with 10% calf
serum (PAA Laboratories, Linz, Austria). Phosphate-buff-
ered saline (PBS) was used to dilute detached cells from
one 25 cm2 culture flask and make aliquots of 10 000,
1000 or 250 cells. The cells were stored in lysis buffer
(Stratagene, La Jolla, CA) at -70°C. Total RNA from 10
000 cells aliquots were isolated using Microprep kit (Strat-
agene), while the Nanoprep kit (Stratagene) was used for
isolation of total RNA from 1000 and 250 cell samples.
The eluted RNA was immediately applied in the subse-
quent amplification procedure.
RNA amplification
Two rounds of RNA amplification were carried out as
described earlier [12]. For the 1000 and 250 cell samples,
all volumes in the amplification procedure were reduced
by a factor of 0.5 with the exception of in vitro transcrip-
tion reactions. They were performed in the standard vol-
ume quantity suggested by the manufacturer. The reason
for decreasing the reaction volumes was to reduce the dif-
ference in the primer to template ratio and thus minimize
possible production of primer-dependent products.
Briefly, the eluted total RNA was speed vacuumed with a
primer annealing mix consisting of a dT/T7 primer, syn-
thetic reference RNA (Lucidea Universal Scorecard refer-
ence RNA, Amersham Pharmacia Biotech AB, Uppsala,
Sweden) in the case of 10 000 cell samples, and synthetic
test RNA (Lucidea Universal Scorecard test RNA, Amer-
sham Pharmacia Biotech AB) plus 40 ng of tRNA in the
1000 and 250 samples. Both reference and test Scorecard
RNA contained one set of calibration control templatesPage 12 of 16
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trol templates (rYIR1-rYIR8). We diluted 3 × 1 µl of score-
card RNA by the following scheme: 10 × dilution of
Lucidea reference RNA was added to RNA from 10 000
cells, while 100 × and 400 × dilution of Lucidea test RNA
was added to RNA from 1000 and 250 cells, respectively.
Second strand synthesis was initiated by RNase digestion.
The purified double stranded cDNA served as template for
the first round of aRNA transcription. In the second round
of amplification, the first strand cDNA was synthesized by
priming with random hexameres. Second strand cDNA
synthesis was initiated by annealing a dT/T7 primer to the
aRNA/cDNA heteroduplex with partially digested aRNA.
A second in vitro transcription reaction followed. The
concentration of aRNA was determined by OD260 reading
in 50 mM NaOH. An mRNA Nano Chip (Agilent Technol-
ogies, Palo Alto, CA) was used to examine the aRNA prod-
ucts on an Agilent 2100 Bioanalyzer.
RNA labeling
The amounts of aRNA used in labeling reactions were; 1
µg of aRNA from 10 000 cells, 0.5 µg aRNA from 1000
cells, and 0.2 µg aRNA from 250 cells. An indirect labeling
procedure (FairPlay Microarray labeling kit, Stratagene)
was performed according to the manufacturer's protocol.
Random hexamers (8 µg) were used to prime the cDNA
synthesis. Labeled Cy5- and Cy3-cDNA was eluted from
their respective columns using 50 µl Tris-HCl (pH = 8.5),
then mixed with 20 µg of human cot-DNA (Invitrogen,
Carlsbad, CA) and 300 µl 0.5 × TE. The mixture was con-
centrated to ~10 µl using Microcon YM-30 columns (Ami-
con, Millipore Corporation, Bedford, MA) before the
addition of SlideHyb#3 hybridization buffer (Ambion
Inc, Austin, TX) to a total volume of 112 µl.
Hybridization and scanning
The hybridization mixture was heated to 100°C for 3 min
and subsequently centrifuged at 13 K r.p.m. for 10 min
before applying to the microarray slides fitted in hybridi-
zation chambers to a GeneTac automatic hybridization
station (Genomic Solutions, Ann Arbor, MI) for overnight
hybridization at 65°C. Prior to scanning, the slides were
washed in the following solutions: 2 × SSC and 0.1% SDS,
1 × SSC and 0.1% SDS on the hybridization stations,
while two washes in 0.05 × SSC were performed manu-
ally. The slides were dried by centrifugation. Scanning was
performed with an Agilent DNA Microarray Scanner,
model BA (Agilent Technologies, Palo Alto, CA) at 100%
laser value and variable PMT values for optimal signal
acquisition. Data from the images were acquired using
GenePix Pro 4.0 software (Axon Instruments Inc., Union
City CA).
Description of experiments
Three aliquots of 10 000 cells were amplified in parallel
and used as reference against three amplified aliquots of
1000 and 250 cells, respectively. Hence, using a dye swap
strategy, six arrays were hybridized using aRNA from rep-
licates of 10 000 cells as a reference against aRNA from
1000 cell sample replicates. Likewise, six arrays were
hybridized using 250 cell sample replicates versus refer-
ence. Thus, in total there were twelve arrays. The experi-
mental design is presented in Fig. 1. The microarray slides
were all from the same print batch.
Data preparation
From the data for each microarray we first manually
removed technically flawed spots, and secondly, we
removed spots automatically flagged by the GenePix soft-
ware as not found. No additional data preparation was
included prior to analysis based on TransCount because
this method handles even very noisy data, and normaliza-
tion is incorporated into the model. For the array quality
index, multiple hypothesis testing and ANOVA analysis,
also spots where the spot intensity (uncorrected fore-
ground intensity) was lower than the background inten-
sity plus two standard deviations of the background in
any of the two channels were removed. An overview of the
number of filtered genes is given in Table 2. In addition,
systematic errors were corrected by normalizing the data
using the locally weighted scatterplot smoother, lowess, as
described in Yang et al. [47].
Array quality index
To ensure that the intensity in the reference channel (10
000 cell samples) did not dominate the log ratios due to
differences in the amount labelled of the two comparative
targets, we explored the following two parameters using
filtered and normalized data. First, the SD of the log10-
intensities of the test channel (target prepared from either
1000 cell or 250 cell samples) was calculated to give an
indication of the dynamic range. Secondly, the correlation
between log10-ratios versus the log10-intensities of the ref-
erence channel (10 000 cell sample) was calculated for the
genes on each array to detect reference channel domina-
tion. The two parameters for each array are listed in Table
3. Scorecard genes were removed prior to this analysis.
Multiple hypothesis testing
To identify genes with log2-ratios significantly different
from 0, p-values were first calculated for each gene using
a moderated t-test [20]. The moderated t-test applied is
based on empirical Bayes analysis and is equivalent to
shrinkage (or expansion) of the estimated sample vari-
ances towards a pooled estimate, resulting in a more sta-
ble inference when the number of microarray experiments
is small. Separate analyses were performed for the experi-
ments involving 10 000 cells vs. 1000 cells and 10 000 vs.Page 13 of 16
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not differentially expressed was estimated using the con-
vex decreasing density estimator of Langaas et al. [48]. The
method is built upon the assumption that the distribu-
tions of the p-values for the genes that are not differen-
tially expressed follow a uniform distribution. Finally,
adjusted p-values were calculated using the Benjamini-
Hochberg step-up procedure [49], taking the estimated
proportion of genes not differentially expressed into
account. Using a cut-off of the adjusted p-values at 0.05
gives an approximate level of False Discovery Rate (FDR)
at 0.05.
The moderated t-test and the convex decreasing density
estimator were implemented in the Limma R package
available as part of the Bioconductor project [50].
Analysis of variance modeling
To investigate the different sources of variability, we set up
an ANOVA-based statistical model. Related models are
found in Kerr et al. [51], Wolfinger et al. [52], Jin et al. [53]
and Nygaard et al. [12]. Let log2  denote the log2-
transform of the normalized measured ratio (signal from
1000 or 250 cells divided by signal from 10 000 cells) for
gene g on array a, for cell sample size c, for replicates b, b1
or b2, having dye ratio case d. We explain the log2-trans-
formed ratio by the following model:
with c = 0,1, d = 0,1, a = 1,...,12, g = 1,...,10643, b = 0,1,2,
b1 = 0,1,2, b2 = 0,1,2, where µ is the overall mean, Aa is the
overall array effect of array a, Cc is the overall cell sample
size effect of cell sample size c, Dd is the overall dye effect
of dye ratio case d, and Gg is the overall gene effect of gene
g. Furthermore, CGcg is the interaction between cell sam-
ple size and gene, so if this effect is significant, the cell
sample size has different effect for different genes. (-1)d
DGg represents the gene-specific dye ratio effect. BGbg
(  and  similarly) models different effect of
genes for different replicates i.e. BGbg is the effect of gene g
and replicate b of the 10 000 cell sample size. µ, Cand D
are fixed effects, the others are random effects. B, B1 and B2
could have been included as random effects in the model,
but the number of repetitions was too small. They should
therefore have been fixed effects instead. However, as they
are confounded with each other and C and D, and as we
expect them to be 0, they have not been included as single
effects in the model. The parameters in the mixed-effects
ANOVA model were estimated using Gibbs-sampling. We
refer to Follestad et al. [54] for estimation details.
TransCount-based absolute transcript concentration 
estimation
The TransCount model is based on the idea of following
the mRNA molecules through the microarray experiment,
from cDNA synthesis to hybridization and subsequent
washing, incorporating available information about the
experiment. The process is modelled as a stepwise selec-
tion, where each molecule has a certain probability of
being kept in the experiment. Using a Bayesian technique,
the highly multivariate joint posterior distribution of all
transcript concentrations is estimated. Details about the
model and estimation method are found in the article by
Frigessi et al. [19].
The model was first applied to spikes in the reference sam-
ple (10 000 cells). Expression data from synthetic Score-
card calibration control templates pre-diluted in a serial
manner by the manufacturer was incorporated into the
TransCount model to obtain the respective absolute con-
centration measurements. We chose three spikes based on
signal intensities situated clearly within the boundaries of
saturation and background levels to calculate a conver-
sion factor. This factor was obtained using linear regres-
sion and information about the known spike
concentrations per cell. Furthermore, the conversion fac-
tor was used to estimate absolute transcript concentra-
tions for each gene in the reference cell sample. These
estimates represented the number of transcripts per cell
before amplification. The transcript concentrations for the
test samples 1000 and 250 were also estimated using the
TransCount method. The results from TransCount were
used to calculate the distribution of the Pearson correla-
tion coefficients between transcript concentrations for dif-
ferent sample sizes. The correlation for a certain
concentration c was computed from genes with concen-
trations in a small interval around c.
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